Healthcare -
Biotechnology - NASDAQ - US
$ 4.55
-1.73 %
$ 156 M
Market Cap
-1.72
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
27.85%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Protara Therapeutics, Inc.
TARA has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart TARA
EBIT FORECAST
EBIT Forecast Chart TARA
NET INCOME FORECAST
Net Income Chart TARA